Inge Platteel - Concepedia

Author

Inge Platteel

University of Groningen

Also Known As

I. Platteel, Inge Platteel

Publications

633

Citations

H-Index

Concepts

All Affiliations

University of Groningen University Medical Center Groningen The Netherlands Cancer Institute Netherlands Comprehensive Cancer Organisation Oncode Institute

About

Inge Platteel is an author at University of Groningen specializing in oncology, medicine, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	197
2	Pathology	3	3	162
3	Obstetrics	2	2	80
4	Immunology	1	1	35
5	Neurology	1	1	62

Inge Platteel

Publications

624

Citations

H-Index

Page 1

	Year	Citations
Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma Liqiang Qi, Joost Bart, Inge Platteel, BMC Cancer	2009	226
TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme Jos M.A. Kuijlen, Jan Jakob A. Mooij, Inge Platteel, Journal of Neuro-Oncology Neuro-oncologyTumoral PathologyTumor InnervationTrail-receptor ExpressionPrimary Glioblastoma Multiforme	2006	62
Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients Jantine L. Westra, Harry Hollema, Michael Schaapveld, Annals of Oncology MedicineColorectal CancerPathologyPredictive ValueThymidylate Synthase	2005	55
Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform Arja ter Elst, Lisette J. Bosman, Inge Platteel, Melanoma Research	2017	55
Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer Wilhelmina E. Hoogendoorn, Harry Hollema, Hester H. van Boven, Breast Cancer Research and Treatment Breast OncologyTamoxifen TreatmentMedicineCancer ManagementPathology	2007	45
The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization Wenjiao Zeng, Annette S.H. Gouw, Marius C. van den Heuvel, Hepatology	2008	38
P53‐specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy Annechien J.A. Lambeck, Ninke Leffers, Baukje‐Nynke Hoogeboom, International Journal of Cancer ImmunologyImmunoeditingGynecologyP53 ProteinImmunotherapy	2007	35
Common and Rare EGFR and KRAS Mutations in a Dutch Non-Small-Cell Lung Cancer Population and Their Clinical Outcome Gerald S. M. A. Kerner, Ed Schuuring, Johanna Sietsma, PLoS ONE	2013	34
Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure Renske Fles, Wilhelmina E. Hoogendoorn, Inge Platteel, Genes Chromosomes and Cancer	2010	20
Diagnostic yield of NanoString nCounter FusionPlex profiling in soft tissue tumors Wangzhao Song, Inge Platteel, Albert J.H. Suurmeijer, Genes Chromosomes and Cancer	2020	20

Page 1